Hinckley Times

Hospitals test value of fourth Covid jabs

- By ASHA PATEL leicesters­hospitals.nhs.uk/aboutus/ education-and-research/researchin­novation/get-involved/research-registry

HOSPITALS are running Covid-19 vaccine trials to assess the effectiven­ess of a fourth jab.

Leicester is one of a number of NHS sites across the country taking part in the Cov-Boost studies.

One is looking at the effectiven­ess of a vaccine designed to protect against the Omicron variant when given as a fourth dose booster.

Suleman Nagdi is one of the parAll ticipants of the last month.

Along with other participan­ts, Mr Nagdi was randomly assigned to have either the specific vaccine against the Omicron variant or the Pfizer Covid-19 vaccine.

Mr Nagdi, who is spokesman for the Federation of Muslim Organisati­ons, said “Throughout the pandemic I have been working closely with community groups and been on various calls talking about the importance of the vaccine but also helping to reassure people. trial, which began

“We know that people in black and minority ethnic communitie­s have been at higher risk, so that’s part of the reason I wanted to put myself forward – to do my part in supporting medical science, but also to reassure all communitie­s.”

During the initial vaccinatio­n rollout, Mr Nagdi said there were occasions when people were put off from taking up the vaccinatio­n due to misinforma­tion, often shared family WhatsApp groups.

He said although he understand­s “having the vaccinatio­n is a choice”, he hoped his participat­ion in the trial would be an encouragem­ent to others to get their jabs, too.

Mr Nagdi is keeping a diary of symptoms over seven days and any other adverse events for up to three months. in

the participan­ts will remain on the study for eight months to have blood tests to check for immune markers and to check on the their health.

Other Covid-19 vaccinatio­n studies are planned.

■ Find out more at:

PARTICIPAN­T KEEN TO PLAY PART IN MEDICAL SCIENCE

 ?? ?? TRIAL: Suleman Nagdi has his vaccinatio­n
TRIAL: Suleman Nagdi has his vaccinatio­n

Newspapers in English

Newspapers from United Kingdom